{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:30:25Z","timestamp":1792251025413,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00198-017-4038-8","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T03:08:54Z","timestamp":1492052934000},"page":"2367-2376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates"],"prefix":"10.1007","volume":"28","author":[{"given":"H.","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nakatsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"4038_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16\u201335","journal-title":"J Bone Miner Res"},{"key":"4038_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"4038_CR3","first-page":"273","volume":"12","author":"N Kondo","year":"2015","unstructured":"Kondo N, Yoda T, Fujisawa J, Arai K, Sakuma M et al (2015) Bilateral atypical femoral subtrochanteric fractures in a premenopausal patient receiving prolonged bisphosphonate therapy: evidence of severely suppressed bone turnover. Clin Cases Miner Bone Metab 12:273\u2013277","journal-title":"Clin Cases Miner Bone Metab"},{"key":"4038_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.1550","volume":"27","author":"AC Feldstein","year":"2012","unstructured":"Feldstein AC, Black D, Perrin N, Rosales AG, Friess D et al (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27:977\u2013986","journal-title":"J Bone Miner Res"},{"key":"4038_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2012.10.016","volume":"52","author":"J Schilcher","year":"2013","unstructured":"Schilcher J, Koeppen V, Ranstam J, Skripitz R, Michaelsson K et al (2013) Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 52:389\u2013392","journal-title":"Bone"},{"key":"4038_CR6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00198-015-3382-9","volume":"27","author":"H Sato","year":"2016","unstructured":"Sato H, Kondo N, Wada Y, Nakatsue T, Iguchi S et al (2016) The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates. Osteoporos Int 27:1217\u20131225","journal-title":"Osteoporos Int"},{"key":"4038_CR7","first-page":"46","volume":"140","author":"SK Bhadada","year":"2014","unstructured":"Bhadada SK, Sridhar S, Muthukrishnan J, Mithal A, Sharma DC et al (2014) Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res 140:46\u201354","journal-title":"Indian J Med Res"},{"key":"4038_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2015.22.1.1","volume":"22","author":"GI Im","year":"2015","unstructured":"Im GI, Jeong SH (2015) Pathogenesis, management and prevention of atypical femoral fractures. J Bone Metab 22:1\u20138","journal-title":"J Bone Metab"},{"key":"4038_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bone.2014.04.012","volume":"64","author":"K Iwata","year":"2014","unstructured":"Iwata K, Mashiba T, Hitora T, Yamagami Y, Yamamoto T (2014) A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy. Bone 64:183\u2013186","journal-title":"Bone"},{"key":"4038_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bone.2015.08.002","volume":"81","author":"C Acevedo","year":"2015","unstructured":"Acevedo C, Bale H, Gludovatz B, Wat A, Tang SY et al (2015) Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone. Bone 81:352\u2013363","journal-title":"Bone"},{"key":"4038_CR11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC et al (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"4038_CR12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00198-008-0585-3","volume":"19","author":"M Saito","year":"2008","unstructured":"Saito M, Mori S, Mashiba T, Komatsubara S, Marumo K (2008) Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int 19:1343\u20131354","journal-title":"Osteoporos Int"},{"key":"4038_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.30135","volume":"63","author":"SL Teitelbaum","year":"2011","unstructured":"Teitelbaum SL, Seton MP, Saag KG (2011) Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Arthritis Rheum 63:325\u2013328","journal-title":"Arthritis Rheum"},{"key":"4038_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.54.10.801","volume":"54","author":"NF Peel","year":"1995","unstructured":"Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801\u2013806","journal-title":"Ann Rheum Dis"},{"key":"4038_CR15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","volume":"17","author":"Y Cao","year":"2002","unstructured":"Cao Y, Mori S, Mashiba T, Westmore MS, Ma L et al (2002) Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 17:2237\u20132246","journal-title":"J Bone Miner Res"},{"key":"4038_CR16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.bone.2010.02.030","volume":"46","author":"MD Martinez","year":"2010","unstructured":"Martinez MD, Schmid GJ, McKenzie JA, Ornitz DM, Silva MJ (2010) Healing of non-displaced fractures produced by fatigue loading of the mouse ulna. Bone 46:1604\u20131612","journal-title":"Bone"},{"key":"4038_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jocd.2013.06.004","volume":"16","author":"MJ McKenna","year":"2013","unstructured":"McKenna MJ, van der Kamp S, Heffernan E, Hurson C (2013) Incomplete atypical femoral fractures: assessing the diagnostic utility of DXA by extending femur length. J Clin Densitom 16:579\u2013583","journal-title":"J Clin Densitom"},{"key":"4038_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2009.11.002","volume":"13","author":"FE McKiernan","year":"2010","unstructured":"McKiernan FE (2010) Atypical femoral diaphyseal fractures documented by serial DXA. J Clin Densitom 13:102\u2013103","journal-title":"J Clin Densitom"},{"key":"4038_CR19","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728\u20131737","journal-title":"N Engl J Med"},{"key":"4038_CR20","doi-asserted-by":"crossref","unstructured":"Hyodo K, Nishino T, Kamada H, Nozawa D, Mishima H, et al. (2016) Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases. J Bone Miner Metab.","DOI":"10.1007\/s00774-016-0747-x"},{"key":"4038_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bone.2014.06.008","volume":"66","author":"Y Saita","year":"2014","unstructured":"Saita Y, Ishijima M, Mogami A, Kubota M, Baba T et al (2014) The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment. Bone 66:105\u2013110","journal-title":"Bone"},{"key":"4038_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00774-012-0358-0","volume":"30","author":"S Sasaki","year":"2012","unstructured":"Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y (2012) Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. J Bone Miner Metab 30:561\u2013567","journal-title":"J Bone Miner Metab"},{"key":"4038_CR23","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267\u20132294","journal-title":"J Bone Miner Res"},{"key":"4038_CR24","first-page":"269","volume":"12","author":"S Arakawa","year":"2015","unstructured":"Arakawa S, Saito M, Kubota M, Suzuki H, Tsuchida S et al (2015) Applying low-intensity pulsed ultrasounds (LIPUS) to a zoledronate-associated atypical femoral shaft fracture without cessation of zoledronate therapy for 3 years follow up: a case report. Clin Cases Miner Bone Metab 12:269\u2013272","journal-title":"Clin Cases Miner Bone Metab"},{"key":"4038_CR25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/jbmr.2547","volume":"30","author":"J Schilcher","year":"2015","unstructured":"Schilcher J, Howe TS, Png MA, Aspenberg P, Koh JS (2015) Atypical fractures are mainly subtrochanteric in Singapore and diaphyseal in Sweden: a cross-sectional study. J Bone Miner Res 30:2127\u20132132","journal-title":"J Bone Miner Res"},{"key":"4038_CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-014-0586-6","volume":"32","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Nawata H, Soen S, Fujiwara S, Nakayama H et al (2014) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab 32:337\u2013350","journal-title":"J Bone Miner Metab"},{"key":"4038_CR27","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","volume":"362","author":"CM Girgis","year":"2010","unstructured":"Girgis CM, Sher D, Seibel MJ (2010) Atypical femoral fractures and bisphosphonate use. N Engl J Med 362:1848\u20131849","journal-title":"N Engl J Med"},{"key":"4038_CR28","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ (2016) Postmenopausal osteoporosis. N Engl J Med 374:2096\u20132097","journal-title":"N Engl J Med"},{"key":"4038_CR29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A, Cooper C, Davies C et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75:392\u2013396","journal-title":"Maturitas"},{"key":"4038_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung M, Harris ST, Miller PD, Bauer DC, Davison KS et al (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13\u201320","journal-title":"Am J Med"},{"key":"4038_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00774-014-0591-9","volume":"33","author":"Y Saita","year":"2015","unstructured":"Saita Y, Ishijima M, Mogami A, Kubota M, Baba T et al (2015) The incidence of and risk factors for developing atypical femoral fractures in Japan. J Bone Miner Metab 33:311\u2013318","journal-title":"J Bone Miner Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4038-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4038-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4038-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T21:11:33Z","timestamp":1569013893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4038-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4038-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}